Elżbieta Jabłonowska

Biographic Data

ID8938956
NAMEElżbieta Jabłonowska
GIVEN NAMESElżbieta
FAMILY NAMEJabłonowska
SIGNATUREJABŁONOWSKA E
AFFILIATIONSMedical University of Lodz
ORCID0000-0002-7282-1225
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2018
LATEST PUBLICATION YEAR2020
H-INDEX0

  • Real life results of direct acting antiviral therapy for HCV infection in HIV–HCV-coinfected patients

    Anna Piekarska, Elżbieta Jabłonowska et al.ARTICLEAIDS Care2020

    The aim of this study was to evaluate the baseline demographics and real-life efficacy of direct acting antivirals (DAAs) in HIV–HCV-positive patients as compared to patients with HCV monoinfection. The analysis included 5690 subjects who were treated with DAAs: 5533 were HCV-positive and 157 were HIV–HCV-positive. Patients with HCV-monoinfection were older (p .05). They were, however, influenced by HCV genotype (p < .0001), stage of hepatic fibr…

  • The high incidence of late presenters for HIV/Aids infection in the Lodz province, Poland in the years 2009–2016

    Kamila Wójcik-Cichy, Kamila Wójcik et al.ARTICLEAIDS Care2018

    The present study retrospectively analyses the prevalence of late diagnosis in patients with newly-diagnosed HIV infection in Lodz, Poland from January 2009 to December 2016, and assesses the predictive factors associated with late presenters. Late presentation is defined as a diagnosis of HIV with a CD4 count<350 cells/μL, or the occurrence of an AIDS- defining event, regardless of the CD4 cell count. Two hundred and fifty-nine (62.86%) patients…